163 related articles for article (PubMed ID: 29848706)
1. Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells.
Kim N; Kang MJ; Lee SH; Son JH; Lee JE; Paik WH; Ryu JK; Kim YT
Anticancer Res; 2018 Jun; 38(6):3527-3533. PubMed ID: 29848706
[TBL] [Abstract][Full Text] [Related]
2. Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells.
Kim N; Lee SH; Son JH; Lee JM; Kang MJ; Kim BH; Lee JS; Ryu JK; Kim YT
Anticancer Res; 2016 Nov; 36(11):6109-6116. PubMed ID: 27793939
[TBL] [Abstract][Full Text] [Related]
3. Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells.
Chen J; Wu SY; Ou-Yang ZG; Zhen YS
Acta Pharmacol Sin; 2008 May; 29(5):614-9. PubMed ID: 18430374
[TBL] [Abstract][Full Text] [Related]
4. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
Wissniowski TT; Meister S; Hahn EG; Kalden JR; Voll R; Ocker M
Int J Oncol; 2012 May; 40(5):1581-9. PubMed ID: 22266985
[TBL] [Abstract][Full Text] [Related]
5. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
Jiang C; Yi XP; Shen H; Li YX
World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919
[TBL] [Abstract][Full Text] [Related]
6. Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study.
Brandi G; Tavolari S; Guarnieri T; Di Marco M; Paterini P; Macchini M; Di Girolamo S; Papi A; De Rosa F; Biasco G
Pancreas; 2014 Jan; 43(1):53-63. PubMed ID: 24201777
[TBL] [Abstract][Full Text] [Related]
7. The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
Youns M; Abdel Halim Hegazy W
PLoS One; 2017; 12(1):e0169335. PubMed ID: 28052097
[TBL] [Abstract][Full Text] [Related]
8. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.
Yotsumoto F; Fukami T; Yagi H; Funakoshi A; Yoshizato T; Kuroki M; Miyamoto S
Cancer Sci; 2010 Nov; 101(11):2351-60. PubMed ID: 20726858
[TBL] [Abstract][Full Text] [Related]
9. Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.
Awasthi N; Zhang C; Hinz S; Schwarz MA; Schwarz RE
J Exp Clin Cancer Res; 2013 Mar; 32(1):12. PubMed ID: 23497499
[TBL] [Abstract][Full Text] [Related]
10. Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.
Waters AM; Khatib TO; Papke B; Goodwin CM; Hobbs GA; Diehl JN; Yang R; Edwards AC; Walsh KH; Sulahian R; McFarland JM; Kapner KS; Gilbert TSK; Stalnecker CA; Javaid S; Barkovskaya A; Grover KR; Hibshman PS; Blake DR; Schaefer A; Nowak KM; Klomp JE; Hayes TK; Kassner M; Tang N; Tanaseichuk O; Chen K; Zhou Y; Kalkat M; Herring LE; Graves LM; Penn LZ; Yin HH; Aguirre AJ; Hahn WC; Cox AD; Der CJ
Cell Rep; 2021 Jun; 35(13):109291. PubMed ID: 34192548
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells.
Zhao Y; Shen S; Guo J; Chen H; Greenblatt DY; Kleeff J; Liao Q; Chen G; Friess H; Leung PS
J Surg Res; 2006 Dec; 136(2):325-35. PubMed ID: 17054996
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D
Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312
[TBL] [Abstract][Full Text] [Related]
14. Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.
Lewis CS; Voelkel-Johnson C; Smith CD
Oncotarget; 2016 Sep; 7(37):60181-60192. PubMed ID: 27517489
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.
Bocci G; Fioravanti A; Orlandi P; Bernardini N; Collecchi P; Del Tacca M; Danesi R
Br J Cancer; 2005 Aug; 93(3):319-30. PubMed ID: 16052215
[TBL] [Abstract][Full Text] [Related]
16. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
Chen H; Wei W; Guo Y; Liu A; Tong H; Wang Z; Tan W; Liu J; Lin S
Oncol Rep; 2011 May; 25(5):1253-61. PubMed ID: 21305255
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cells.
Serra JM; Gutiérrez A; Alemany R; Navarro M; Ros T; Saus C; Ginés J; Sampol A; Amat JC; Serra-Moisés L; Martín J; Galmés A; Vögler O; Besalduch J
Mol Pharmacol; 2008 Jun; 73(6):1679-87. PubMed ID: 18353995
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.
Gu YM; Ma YH; Zhao WG; Chen J
World J Gastroenterol; 2011 Sep; 17(33):3810-7. PubMed ID: 21987623
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation.
Tang Y; Liu F; Zheng C; Sun S; Jiang Y
J Exp Clin Cancer Res; 2012 Sep; 31(1):73. PubMed ID: 22967941
[TBL] [Abstract][Full Text] [Related]
20. Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells.
Ricciardi S; Mey V; Nannizzi S; Pasqualetti G; Crea F; Del Tacca M; Danesi R
Chemotherapy; 2010; 56(4):303-12. PubMed ID: 20714148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
